Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. (ANTH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ANTH · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Anthera Pharmaceuticals, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
Recent insider transactions
ANTH executive sell shares · ANTH board member insider trading · ANTH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 7, 2017 | TRUEX PAUL F Director | Purchase | 5,000 | $7K | Form 4 |
| Nov 13, 2015 | Hislop Colin Chief Medical Officer | Option | 12,500 | $20K | Form 4 |
| Nov 13, 2015 | Hislop Colin Chief Medical Officer | Sale | 12,500 | $66K | Form 4 |
| Nov 11, 2015 | Hislop Colin Chief Medical Officer | Sale | 5,000 | $27K | Form 4 |
| Oct 12, 2015 | ODINK DEBRA CTO | Sale | 1,205 | $7K | Form 4 |
| Dec 30, 2014 | ODINK DEBRA CTO | Gift | 1,364 | — | Form 4 |
| Dec 30, 2014 | ODINK DEBRA CTO | Gift | 1,364 | — | Form 4 |
| Dec 31, 2014 | TRUEX PAUL F President and CEO | Gift | 12,500 | — | Form 4 |
| Dec 31, 2014 | TRUEX PAUL F President and CEO | Gift | 12,500 | — | Form 4 |
Hislop Colin
Chief Medical Officer
Date
Nov 13
Shares
12,500
Price
$1.61
Value
$20K
Hislop Colin
Chief Medical Officer
Date
Nov 13
Shares
12,500
Price
$5.31
Value
$66K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ANTH insider trading
ANTH insider trades
Anthera Pharmaceuticals, Inc. (ANTH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ANTH. Over the past 12 months, 0 insiders have filed transactions with the SEC. ANTH insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Anthera Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ANTH insider trading · 5 questionsThe insiders of Anthera Pharmaceuticals, Inc. (ANTH) include executives and directors such as ANTH, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026